Research Areas & Departments
TRIPM
The Thumbay Research Institute for Precision Medicine (TRIPM) focuses on key priority areas that address critical challenges in cancer and translational biomedical research:
- Cancer Immunology and Experimental Oncology
Advancing the understanding of tumor–immune interactions to develop innovative immunotherapeutic strategies and improve patient outcomes. - Tumor Genetic Instability and Immunogenicity
Investigating the molecular mechanisms underlying genomic instability and their impact on tumor evolution, immune recognition, and therapy response. - Biomarkers and Functional Genomics
Identifying and validating molecular biomarkers and leveraging functional genomics to support early diagnosis, prognosis, and personalized treatment approaches.
Collaborative and Multidisciplinary Approach
TRIPM’s scientific program is designed to foster strong interactions between academia and industry, integrating expertise from basic scientists, clinicians, and epidemiologists. This multidisciplinary framework enables the translation of fundamental discoveries into clinically relevant applications.
Through strategic partnerships with leading international institutions, TRIPM promotes collaborative research aimed at transforming scientific breakthroughs into innovative diagnostics, therapies, and healthcare solutions. This approach ensures the delivery of high-quality research with meaningful clinical and societal impact.